美国联合医疗(UTHR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

UTHR 美国联合医疗

盘后交易 02-10 17:15:39 EST

473.20

+0.08

+0.02%

盘后473.20

+0.000.00%

16:49 EST

最高475.69	最低468.62	成交量23.40万
今开475.01	昨收473.12	日振幅1.49%
总市值203.74亿	流通市值198.68亿	总股本4,306万
成交额1.11亿	换手率0.56%	流通股本4,199万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"UTHR","market":"US","secType":"STK","nameCN":"美国联合医疗","latestPrice":473.2,"timestamp":1770757200000,"preClose":473.12,"halted":0,"volume":234018,"hourTrading":{"tag":"盘后","latestPrice":473.2,"preClose":473.2,"latestTime":"16:49 EST","volume":14996,"amount":7096105.7004,"timestamp":1770760182136,"change":0,"changeRate":0,"amplitude":0.000465},"delay":0,"changeRate":0.0001690902942170783,"floatShares":41986103,"shares":43056599,"eps":26.376804,"marketStatus":"盘后交易","change":0.08,"latestTime":"02-10 17:15:39 EST","open":475.01,"high":475.69,"low":468.62,"amount":110548937.79036,"amplitude":0.014943,"askPrice":475.03,"askSize":10,"bidPrice":464.02,"bidSize":4,"shortable":3,"etf":0,"ttmEps":26.376804,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770771600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":929592000000,"exchange":"NASDAQ","adjPreClose":473.12,"preHourTrading":{"tag":"盘前","latestPrice":471.86,"preClose":473.12,"latestTime":"08:01 EST","volume":1,"amount":471.86,"timestamp":1770728485559,"change":-1.26,"changeRate":-0.002663,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":473.2,"preClose":473.2,"latestTime":"16:49 EST","volume":14996,"amount":7096105.7004,"timestamp":1770760182136,"change":0,"changeRate":0,"amplitude":0.000465},"volumeRatio":0.642075,"impliedVol":0.4591,"impliedVolPercentile":0.7769},"requestUrl":"/m/hq/s/UTHR","defaultTab":"news","newsList":[{"id":"1196123529","title":"美国联合医疗公布Miroliverelap®治疗急性肝衰竭一期研究积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1196123529","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196123529?lang=zh_cn&edition=full","pubTime":"2026-01-26 20:02","pubTimestamp":1769428924,"startTime":"0","endTime":"0","summary":"美国联合医疗（United Therapeutics）近日披露了其创新药物Miroliverelap®针对急性肝衰竭患者的一期临床试验数据，结果显示疗效积极。该研究评估了药物的安全性与耐受性，初步数据表明患者肝功能指标呈现改善趋势，未出现严重不良反应。这一突破为后续临床研究奠定了基础，有望为急性肝衰竭治疗提供新方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","BK4532","BK4139","LU1699723380.USD","UTHR"],"gpt_icon":0},{"id":"1126950571","title":"美国联合医疗在末期肾病患者的Ukidney扩展临床试验中宣布首次移植","url":"https://stock-news.laohu8.com/highlight/detail?id=1126950571","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126950571?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:01","pubTimestamp":1762171275,"startTime":"0","endTime":"0","summary":"美国联合医疗在末期肾病患者的Ukidney扩展临床试验中宣布首次移植。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UTHR","BK4532","LU1571399168.USD","LU1699723380.USD"],"gpt_icon":0},{"id":"2579937183","title":"美股异动 | Q3业绩好于预期 联合治疗(UTHR.US)大涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579937183","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579937183?lang=zh_cn&edition=full","pubTime":"2025-10-29 23:40","pubTimestamp":1761752407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，联合治疗(UTHR.US)大涨超12%，续创历史新高，报465.38美元。消息面上，10月29日，该公司公布2025年第三季度业绩，每股收益7.16美元，超出分析师预期约0.16美元，净利润达3.387亿美元，同比增长约9.6%。主要产品Tyvaso报告持续两位数增长，推动总收入创纪录达7.995亿美元同比增7%，反映高市场需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362311.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股异动 | Q3业绩好于预期 联合治疗(UTHR.US)大涨超12%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1699723380.USD","LU1571399168.USD","BK4532","BK4139","UTHR"],"gpt_icon":0},{"id":"2579907726","title":"美国联合医疗盘中异动 早盘股价大涨6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579907726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579907726?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:31","pubTimestamp":1761744673,"startTime":"0","endTime":"0","summary":"北京时间2025年10月29日21时31分，美国联合医疗股票出现波动，股价大幅上涨6.18%。美国联合医疗股票所在的制药行业中，整体涨幅为0.21%。此外，该公司正在开发一系列项目，其中包括用于治疗肺动脉高压和其他病症的现有产品和新产品的新适应症和输送装置。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029213113a47bf469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029213113a47bf469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","LU1699723380.USD","UTHR","LU1571399168.USD","BK4139"],"gpt_icon":0},{"id":"1164897405","title":"美国联合医疗将使用Teton数据支持补充新药申请，为雾化Tyvaso增加IPF标示适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1164897405","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164897405?lang=zh_cn&edition=full","pubTime":"2025-09-02 19:05","pubTimestamp":1756811124,"startTime":"0","endTime":"0","summary":"美国联合医疗公司将使用Teton数据支持补充新药申请，为雾化Tyvaso增加IPF标示适应症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR","BK4532","LU1571399168.USD","LU1699723380.USD","BK4139"],"gpt_icon":0},{"id":"1135280556","title":"美国联合医疗：将利用Teton-2研究及进行中的Teton-1研究数据支持雾化Tyvaso补充新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1135280556","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135280556?lang=zh_cn&edition=full","pubTime":"2025-09-02 19:03","pubTimestamp":1756810991,"startTime":"0","endTime":"0","summary":"美国联合医疗表示，公司计划采用Teton-2研究数据以及目前正在进行的Teton-1研究中雾化Tyvaso的相关数据，为其补充新药申请提供支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1699723380.USD","LU1571399168.USD","BK4139","UTHR"],"gpt_icon":0},{"id":"1194203497","title":"美国联合医疗：Tyvaso治疗耐受性良好，安全性数据与以往研究保持一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1194203497","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194203497?lang=zh_cn&edition=full","pubTime":"2025-09-02 19:01","pubTimestamp":1756810889,"startTime":"0","endTime":"0","summary":"美国联合医疗公司表示，Tyvaso治疗显示出良好的耐受性，其安全性特征与此前进行的Tyvaso相关研究结果保持一致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","LU1571399168.USD","UTHR","LU1699723380.USD"],"gpt_icon":0},{"id":"2516854800","title":"美国联合医疗2024财年实现净利润11.95亿美元，同比增加21.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516854800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516854800?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:00","pubTimestamp":1740931230,"startTime":"0","endTime":"0","summary":"3月3日，美国联合医疗公布财报，公告显示公司2024财年净利润为11.95亿美元，同比增加21.32%；其中营业收入为28.77亿美元，同比增加23.58%，每股基本收益为26.44美元。从资产负债表来看，美国联合医疗总负债9.94亿美元，其中短期债务3.00亿美元，资产负债比为7.49，流动比率为5.25。机构评级：截至2025年3月3日，当前有10家机构对美国联合医疗目标价做出预测，其中目标均价为407.90美元，其中最低目标价为293.00美元，最高目标价为600.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000045abe4ac8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000045abe4ac8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UTHR"],"gpt_icon":0},{"id":"1158292312","title":"异动解读 | 财报利润不佳 美国联合医疗公司股价盘中大跌6.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158292312","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158292312?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:37","pubTimestamp":1740580660,"startTime":"0","endTime":"0","summary":"美国联合医疗今日盘中股价暴跌6.85%,引发市场广泛关注。导致股价大跌的主因是该公司公布的2024年第四季度财报利润不佳。数据显示,联合治疗公司当季每股收益为6.19美元,远低于分析师预期的6.27美元。这一业绩低于预期引发了投资者的担忧,导致其股价在报告当天大幅下挫。综合来看,财报利润不佳造成了投资者对该公司前景的担忧,从而引发了股价在盘中大幅度下跌的走势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["UTHR"],"gpt_icon":0},{"id":"2514856083","title":"美国联合医疗盘中异动 股价大跌5.30%报338.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856083?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580282,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，美国联合医疗股票出现波动，股价快速下跌5.30%。截至发稿，该股报338.54美元/股，成交量1.2718万股，换手率0.03%，振幅0.36%。美国联合医疗股票所在的生物技术行业中，整体涨幅为0.12%。肺动脉高压是一种罕见的进行性疾病，其特征为肺动脉血压异常升高。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物，但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223122a254f640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223122a254f640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","UTHR","BK4139","BK4532","LU1699723380.USD"],"gpt_icon":0},{"id":"1193208884","title":"联合治疗公司2024年第四季度GAAP每股收益6.19美元，低于预期的6.27美元，销售额为7.359亿美元，高于预期的7.3474亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193208884","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193208884?lang=zh_cn&edition=full","pubTime":"2025-02-26 19:37","pubTimestamp":1740569829,"startTime":"0","endTime":"0","summary":"联合治疗公司报告其季度每股收益为6.19美元，低于分析师预期的6.27美元，差距为1.28%。与去年同期每股收益4.36美元相比，这增加了41.97%。该公司报告其季度销售额为7.359亿美元，高于分析师预期的7.3474亿美元，增长了0.16%。以上内容来自Benzinga Earnings专栏，原文如下：United $Therapeutics$  reported quarterly earnings of $6.19 per share which missed the analyst consensus estimate of $6.27 by 1.28 percent. This is a 41.97 percent increase over earnings of $4.36 per share from the same period last year.  The company reported quarterly sales of $735.90 million which beat the analyst consensus estimate of $734.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"联合治疗公司2024年第四季度GAAP每股收益6.19美元，低于预期的6.27美元，销售额为7.359亿美元，高于预期的7.3474亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UTHR"],"gpt_icon":0},{"id":"2510336824","title":"美国联合医疗盘中异动 早盘快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510336824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510336824?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:39","pubTimestamp":1739288398,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时39分，美国联合医疗股票出现波动，股价快速上涨5.01%。美国联合医疗股票所在的生物技术行业中，整体跌幅为1.81%。美国联合医疗公司简介：United Therapeutics Corp 是一家专门从事肺动脉高压的药物研发的公司。肺动脉高压是一种罕见的进行性疾病，其特征为肺动脉血压异常升高。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物，但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211233959abcb1555&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211233959abcb1555&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4532","UTHR","LU1699723380.USD","LU1571399168.USD"],"gpt_icon":0},{"id":"2507675693","title":"美国联合医疗盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507675693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507675693?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:54","pubTimestamp":1738256085,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时54分，美国联合医疗股票出现波动，股价大幅下跌5.05%。截至发稿，该股报353.93美元/股，成交量13.1695万股，换手率0.29%，振幅4.28%。美国联合医疗股票所在的生物技术行业中，整体涨幅为0.17%。肺动脉高压是一种罕见的进行性疾病，其特征为肺动脉血压异常升高。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物，但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013100544696144de4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013100544696144de4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1699723380.USD","BK4139","UTHR","LU1571399168.USD","BK4532"],"gpt_icon":0},{"id":"2492471134","title":"美国联合医疗盘中异动 股价大跌5.12%报360.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492471134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492471134?lang=zh_cn&edition=full","pubTime":"2024-12-19 02:11","pubTimestamp":1734545475,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日02时11分，美国联合医疗股票出现波动，股价快速跳水5.12%。截至发稿，该股报360.26美元/股，成交量21.909万股，换手率0.49%，振幅5.74%。美国联合医疗股票所在的生物技术行业中，整体跌幅为0.53%。肺动脉高压是一种罕见的进行性疾病，其特征为肺动脉血压异常升高。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物，但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219021115984cb5de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219021115984cb5de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","BK4532","BK4139","LU1699723380.USD","UTHR"],"gpt_icon":0},{"id":"2482702756","title":"美国联合医疗跌2.45% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2482702756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482702756?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:10","pubTimestamp":1731348645,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时10分，美国联合医疗股票出现波动，股价急速跳水2.45%。截至发稿，该股报399.95美元/股，成交量21.2335万股，换手率0.48%，振幅3.33%。美国联合医疗股票所在的生物技术行业中，整体跌幅为0.69%。美国联合医疗公司简介：United Therapeutics Corp 是一家专门从事肺动脉高压的药物研发的公司。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物，但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112021045a22d4ad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112021045a22d4ad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1571399168.USD","UTHR","BK4532","LU1699723380.USD"],"gpt_icon":0},{"id":"2481554136","title":"美国联合医疗涨0.71% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2481554136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481554136?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:09","pubTimestamp":1730999347,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日01时09分，美国联合医疗股票出现异动，股价快速拉升0.71%。截至发稿，该股报400.31美元/股，成交量7.6907万股，换手率0.17%，振幅1.32%。美国联合医疗股票所在的生物技术行业中，整体涨幅为0.64%。美国联合医疗公司简介：United Therapeutics Corp 是一家专门从事肺动脉高压的药物研发的公司。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物，但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108010907971a527e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108010907971a527e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4139","LU1571399168.USD","UTHR","LU1699723380.USD"],"gpt_icon":0},{"id":"2480836028","title":"美国联合医疗2024财年第三财季实现净利润3.09亿美元，同比增加15.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480836028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480836028?lang=zh_cn&edition=full","pubTime":"2024-11-04 00:00","pubTimestamp":1730649633,"startTime":"0","endTime":"0","summary":"11月4日，美国联合医疗公布财报，公告显示公司2024财年第三财季净利润为3.09亿美元，同比增加15.30%；其中营业收入为7.49亿美元，同比增加22.99%，每股基本收益为6.93美元。从资产负债表来看，美国联合医疗总负债10.22亿美元，其中短期债务4.00亿美元，资产负债比为6.97，流动比率为4.59。机构评级：截至2024年11月4日，当前有12家机构对美国联合医疗目标价做出预测，其中目标均价为395.83美元，其中最低目标价为302.00美元，最高目标价为600.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000059a211d2b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000059a211d2b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["UTHR"],"gpt_icon":0},{"id":"2477534229","title":"美国联合医疗盘中异动 大幅下挫5.02%报351.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477534229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477534229?lang=zh_cn&edition=full","pubTime":"2024-10-23 23:05","pubTimestamp":1729695954,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日23时05分，美国联合医疗股票出现异动，股价快速下跌5.02%。截至发稿，该股报351.68美元/股，成交量16.1817万股，换手率0.36%，振幅4.91%。机构评级方面，在所有17家参与评级的机构中，53%的券商给予买入建议，35%的券商给予持有建议，12%的券商给予卖出建议。美国联合医疗股票所在的生物技术行业中，整体跌幅为1.20%。该公司的所有销售额都在美国境内产生。该公司还销售一种儿科肿瘤药物，但其重点仍然集中于研究肺动脉高压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102323055598e3e06a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102323055598e3e06a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","BK4139","UTHR","LU1699723380.USD","BK4532"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.unither.com","stockEarnings":[{"period":"1week","weight":-0.004},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0303},{"period":"6month","weight":0.5276},{"period":"1year","weight":0.3607},{"period":"ytd","weight":-0.029}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"United Therapeutics Corporation于1996年成立于特拉华。它是一家生物科技公司，致力于能解决患有慢性病和有生命危险病人未被满足的医疗需求的独特产品的开发和商业化。它的收入主要来源于曲前列尼尔、Tyvaso和他达拉非的销售。他们的市场和销售人员会努力使他们的产品在他们那些被授权的国家买到。这些主要是由他们在美国的专业经销商和其它的国际经销商做的。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.005391},{"month":2,"riseRate":0.518519,"avgChangeRate":0.019314},{"month":3,"riseRate":0.461538,"avgChangeRate":0.007361},{"month":4,"riseRate":0.423077,"avgChangeRate":-0.021475},{"month":5,"riseRate":0.576923,"avgChangeRate":0.049852},{"month":6,"riseRate":0.538462,"avgChangeRate":0.028894},{"month":7,"riseRate":0.592593,"avgChangeRate":0.043947},{"month":8,"riseRate":0.518519,"avgChangeRate":0.052081},{"month":9,"riseRate":0.444444,"avgChangeRate":0.055311},{"month":10,"riseRate":0.62963,"avgChangeRate":-0.003162},{"month":11,"riseRate":0.62963,"avgChangeRate":0.05551},{"month":12,"riseRate":0.592593,"avgChangeRate":0.029941}],"exchange":"NASDAQ","name":"美国联合医疗","nameEN":"United Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美国联合医疗(UTHR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美国联合医疗(UTHR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美国联合医疗,UTHR,美国联合医疗股票,美国联合医疗股票老虎,美国联合医疗股票老虎国际,美国联合医疗行情,美国联合医疗股票行情,美国联合医疗股价,美国联合医疗股市,美国联合医疗股票价格,美国联合医疗股票交易,美国联合医疗股票购买,美国联合医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美国联合医疗(UTHR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美国联合医疗(UTHR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}